Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 3.02, 5.02, 9.01 · 8-K

Adapti, Inc.

Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 1.01 Entry into a Material Definitive Agreement The disclosure in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference into this Item.

Filed Nov 24, 2025Accepted Nov 24, 2025, 5:16 PM ESTCIK 1420924Accession 0001493152-25-024849
Share

Company context

Current securities

Historical securities (5)

Recent company filings

  1. Non-Reliance on Previously Issued Financial Statements or a Related Audit ReportJul 20, 2026
  2. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Other EventsApr 6, 2026
  3. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsMar 6, 2026
  4. 10-Q filingFeb 17, 2026
  5. 10-Q filingNov 19, 2025

Disclosure sections

Items 1.01, 3.02, 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement The disclosure in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference into this Item.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item 3.02 Unregistered Sale of Equity Securities The disclosure in Item 5.02 of this Current Report on Form 8-K regarding the issuance of the Warrant (as defined below) to Mr. Karim is incorporated by reference into this Item. The Warrant is exempt from the registration requirements of the Securities Act of 1933 by virtue of Section 4(a)(2) thereof and/or Regulation D promulgated thereunder. Item 5.02 Departure of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Appointment of Omar Karim as Chief Revenue Officer. On November 18, 2025 (“Effective Date”), Adapti, Inc. (the “Company”) appointed Omar Karim to serve as the Chief Revenue Officer of the Company. Omar Karim, age 44, was appointed to serve as our chief revenue officer in November 2025. From 2002 until November 2025, Mr. Karim was a founder and served as president of MAB Ventures Digital Marketing Agency, LLC until its sale. MAB is a full-service performance marketing agency that specializes in brand strategy, creative execution, end-to-end digital technology, and engagement. Earlier in his career, Mr. Karim managed an automobile dealership, worked as vice-president of business development for PayDivvy, a financial technology startup, which was acquired by HigherOne in 2013, and was a founding member of Fitlab, LLC, an integrated health and wellness venture. Mr. Karim graduated from the University of Southern California and holds a BA in international relations with a double minor in Business Administration and Business Technology. Omar Karim Employment Agreement and Related Contracts On the Effective Date, in connection with Mr. Karim’s employment, we entered into an at-will employment agreement (the “Employment Agreement”) with Mr. Karim. Pursuant to the terms of the Employment Agreement, Mr. Karim will receive a base salary of $180,000 per annum. Such base salary will accrue, but not be payable until the earlier of (i) the Company’s board of directors (“Board”) determining that the Company is sufficiently capitalized or (ii) the Company raises an aggregate of $1,000,000 in net proceeds from the sale of its equity securities in one or more transactions (collectively, the “Funding Threshold”). Upon the Funding Threshold, the Company will be required to pay all accrued but unpaid base salary and such base salary will automatically increase to $300,000 per annum. Upon completion of the Funding Threshold, if Mr. Karim’s employment is terminated for any reason other than “Cause”, “Permanent Disability”, or death, each as described in the Employment Agreement (an “Elective Termination”), then the Company will be required to pay Mr. Karim six (6) months of continued base salary in effect at the time of termination. Common Stock Purchase Warrant In addition, on the Effective Date, the Company issued to Mr. Karim, a warrant to purchase up to 240,000 shares of common stock of the Company (the “Warrant”). The Warrant has a term of five (5) years, and an exercise price per share of $3.08, subject to adjustment for stock splits and dividends. The Warrant vests as follows: (i) 48,000 shares vest on the Effective Date, and (ii) an additional 48,000 shares vest on each yearly anniversary thereafter such that the Warrant is fully vested on the four (4) year anniversary of the Effective Date. The Warrant also vests (i) fully upon a “change of control” of the Company, as defined in the Warrant or (ii) ratably from the most recently completed vesting period until the date of any Elective Termination. Confidential Information and Invention Assignment Agreement In addition, Mr. Karim entered into the Company’s standard confidential information and invention assignment agreement (“Assignment Agreement”) governing the ownership of any inventions and confidential information. There were no arrangements pursuant to which Mr. Karim was appointed as Chief Revenue Officer. There are no family relationships between Mr. Karim and any of the directors or officers of the Company or any of its subsidiaries. The foregoing summary of the Employment Agreement, Warrant and Assignment Agreement are qualified in their entirety by the respective terms of the Employment Agreement, Warrant, and Assignment Agreement, which are attached to this Current Report as Exhibits 10.01, 4.01, and 10.02, respectively.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Appointment of Omar Karim as Chief Revenue Officer. On November 18, 2025 (“Effective Date”), Adapti, Inc. (the “Company”) appointed Omar Karim to serve as the Chief Revenue Officer of the Company. Omar Karim, age 44, was appointed to serve as our chief revenue officer in November 2025. From 2002 until November 2025, Mr. Karim was a founder and served as president of MAB Ventures Digital Marketing Agency, LLC until its sale. MAB is a full-service performance marketing agency that specializes in brand strategy, creative execution, end-to-end digital technology, and engagement. Earlier in his career, Mr. Karim managed an automobile dealership, worked as vice-president of business development for PayDivvy, a financial technology startup, which was acquired by HigherOne in 2013, and was a founding member of Fitlab, LLC, an integrated health and wellness venture. Mr. Karim graduated from the University of Southern California and holds a BA in international relations with a double minor in Business Administration and Business Technology. Omar Karim Employment Agreement and Related Contracts On the Effective Date, in connection with Mr. Karim’s employment, we entered into an at-will employment agreement (the “Employment Agreement”) with Mr. Karim. Pursuant to the terms of the Employment Agreement, Mr. Karim will receive a base salary of $180,000 per annum. Such base salary will accrue, but not be payable until the earlier of (i) the Company’s board of directors (“Board”) determining that the Company is sufficiently capitalized or (ii) the Company raises an aggregate of $1,000,000 in net proceeds from the sale of its equity securities in one or more transactions (collectively, the “Funding Threshold”). Upon the Funding Threshold, the Company will be required to pay all accrued but unpaid base salary and such base salary will automatically increase to $300,000 per annum. Upon completion of the Funding Threshold, if Mr. Karim’s employment is terminated for any reason other than “Cause”, “Permanent Disability”, or death, each as described in the Employment Agreement (an “Elective Termination”), then the Company will be required to pay Mr. Karim six (6) months of continued base salary in effect at the time of termination. Common Stock Purchase Warrant In addition, on the Effective Date, the Company issued to Mr. Karim, a warrant to purchase up to 240,000 shares of common stock of the Company (the “Warrant”). The Warrant has a term of five (5) years, and an exercise price per share of $3.08, subject to adjustment for stock splits and dividends. The Warrant vests as follows: (i) 48,000 shares vest on the Effective Date, and (ii) an additional 48,000 shares vest on each yearly anniversary thereafter such that the Warrant is fully vested on the four (4) year anniversary of the Effective Date. The Warrant also vests (i) fully upon a “change of control” of the Company, as defined in the Warrant or (ii) ratably from the most recently completed vesting period until the date of any Elective Termination. Confidential Information and Invention Assignment Agreement In addition, Mr. Karim entered into the Company’s standard confidential information and invention assignment agreement (“Assignment Agreement”) governing the ownership of any inventions and confidential information. There were no arrangements pursuant to which Mr. Karim was appointed as Chief Revenue Officer. There are no family relationships between Mr. Karim and any of the directors or officers of the Company or any of its subsidiaries. The foregoing summary of the Employment Agreement, Warrant and Assignment Agreement are qualified in their entirety by the respective terms of the Employment Agreement, Warrant, and Assignment Agreement, which are attached to this Current Report as Exhibits 10.01, 4.01, and 10.02, respectively.
Filed exhibits (1)
EX-4.1 (by filename) ex4-01.htm

EX-4.01 2 ex4-01.htm EX-4.01 Exhibit 4.01 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. COMMON STOCK PURCHASE WARRANT ADAPTI, Inc. Warrant Initial Shares: 240,000 Exercise Date: November 18, 2025 THIS COMMON STOCK PURCHASE WARRANT (the “ Warrant ”) certifies that, for value …

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.